California Voters Will Decide Immunology Research Funding
In November 2026, California residents will vote on a ballot measure to issue $8.4 billion in bonds for medical research.
Updated on Oct. 1, 2026 in Asthma
Live Poll
Should California issue billions in bonds to fund private medical research institutes?
Proposition 38 would authorize $8.4 billion in state bonds to fund immunology research focused on cancer, heart disease, and Alzheimer's disease. If passed, the measure would direct funds to qualifying research institutions starting in November 2026.
Why it matters
Proponents argue that the measure will address gaps in federal science funding by providing a dedicated state revenue stream for medical breakthroughs. The bond repayment is estimated to cost taxpayers between $500 million and $600 million annually for approximately 20 years.
The proposal mandates that at least $4.2 billion be allocated specifically for immunology research across cancer, heart disease, and Alzheimer's. Eligible institutions must meet strict criteria, including 200,000 square feet of research space and significant philanthropic commitments.
The players
California Institute for Immunology
A research entity with institutional ties to UCLA that would be impacted by the potential funding.
Stanford School of Medicine
A premier medical research institution home to experts examining the impact of state-funded research initiatives.
The details
The bond-funded program aims to accelerate immunotherapy research by awarding competitive grants through a council of university and institutional representatives. To qualify for these grants, institutions must secure $250 million in philanthropic support, commit two $50-million research pledges, and maintain formal affiliation agreements with a University of California campus. These requirements ensure that only well-established research hubs with proven scale and infrastructure can participate in the funded projects.
Timeline
2004: Voters approved Proposition 71 for stem cell research.
2020: Voters approved Proposition 14 for stem cell research.
January 1, 2025: Qualification start date for research institutions.
Mid-September 2026: Yes on 38 campaign held a virtual news conference.
November 2026: California voters decide on Proposition 38.
Health Landscape
Proposition 38 continues the precedent set by the 2020 Proposition 14 measure in prioritizing state-led scientific funding. This initiative seeks to solidify California's status as a hub for immunology, building on a history of state-funded research programs.
Residents should review the ballot measure details to understand the potential fiscal impact on state taxpayers and the intended research focus areas. If you are interested in how this might affect the availability of clinical trials, consider discussing these long-term research goals with your doctor.
The takeaway
Proposition 38 represents a significant effort to shift medical research funding to the state level. Voters should track the measure's language regarding institutional accountability to ensure transparency in how billions in taxpayer-backed funds are deployed for immunology advancements.
Further reading
Learn more about the latest developments in local treatment options on our California Asthma page.
Source note: This article includes information reported by Los Angeles Times.
Live Poll
Should California issue billions in bonds to fund private medical research institutes?
